184
Participants
Start Date
December 17, 2019
Primary Completion Date
December 17, 2024
Study Completion Date
December 17, 2024
Atezolizumab
Atezolizumab will be administered at a dose of 840 mg via IV infusion on Days 1 and 15 of every 28-day cycle. Day 15: Atezolizumab may be administered on Days 15-18 of each cycle.
Nab-Paclitaxel
Nab-Paclitaxel will be administered at the 100 mg/m2 dose via IV infusion on Days 1, 8, and 15 of every 28-day cycle. Day 8: Nab-paclitaxel may be administered on Days 8-11 of each cycle. Day 15: Nab-paclitaxel may be administered on Days 15-18 of each cycle, on the same day with the atezolizumab infusion.
Hospital Nacional Cayetano Heredia, Lima
Institute of Oncology Ljubljana, Ljubljana
Univerzitetni klini?ni center Maribor, Maribor
Komarom-Eszergom Varmegyei Szent Borbala Korhaz, Tatabánya
B-A-Z Vármegyei Központi Kórház és Egyetemi Oktatókórház, Miskolc
Debreceni Egyetem Klinikai Kozpont, Debrecen
Bács-Kiskun Vármegyei Oktatókórház, Kecskemét
Zala Vármegyei Szent Rafael Kórház, Zalaegerszeg
Fondazione del Piemonte per l?Oncologia (IRCCS), Candiolo
Instituto Nacional de Cancerologia, Distrito Federal
Instituto Nacional de Enfermedades Neoplasicas, Lima
Hospital Universitario San Cecilio, Granada
Irccs Ospedale San Raffaele, Milan
Istituto Europeo Di Oncologia, Milan
Ospedale San Gerardo, Monza
Institut de Cancérologie de Bourgogne, Dijon
Hospital Universitari Arnau de Vilanova de Lleida, Lleida
Hospital Lucus Augusti, Lugo
Fondazione IRCCS Policlinico San Matteo, Oncologia, Pavia
Hospital Universitario 12 de Octubre, Madrid
Hospital Clinico Universitario Virgen de la Victoria, Málaga
Hospital General Universitario J.M Morales Meseguer, Murcia
Institut de cancerologie du Gard, Nîmes
AULSS3 - Presidio di Mirano, Mirano (VE)
Hospital Univ. Central de Asturias, Oviedo
Hospital Alvaro Cunqueiro, Vigo
Hospital Clinico Universitario de Salamanca, Salamanca
Ospedale Santa Chiara, Trento
Hospital de Basurto, Bilbao
Azienda ospedaliero-universitaria careggi, Sezione di radioterapia del dipartimento di fisiopatolo, Florence
Azienda Ospedaliero - Universitaria Pisana U.O. Oncologia Medica 2 Universitaria ? Polo Oncologico, Pisa
Nuovo Ospedale di Prato S. Stefano - Azienda USL Toscana Centro, Prato
Clinique Onco Des Dentellieres, Valenciennes
Clinica Oncologica-Ospedali Riuniti Ancona, Torrette
Centre Leon Berard, Lyon
Azienda Ospedaliera San Giuseppe Moscati, Avellino
Azienda Universitaria Magna Grecia, Catanzaro
Hôpital Franco-Britannique- Fondation Cognacq-Jay, Levallois-Perret
Departement Medecine, Villejuif
Ospedale Cannizzaro, Oncologia, Catania
Centrul de Oncologie Sfantul Nectarie, Craiova
Prof. Dr. I. Chiricuta Institute of Oncology, Cluj-Napoca
Centrul de Radioterapie AMETHYST, Floreşti
Instituto de Radiomedicina, IRAM, Santiago
CEMIC, Buenos Aires
Sanatorio de la Mujer, Rosario
Organizacion Medica de Investigacion, San Nicolás
Pontificia Universidad Catolica de Chile, Santiago
Nemocnice AGEL Novy Jicin a.s., Nový Jičín
Fakultni Poliklinika Vseobecne Fakultni Niemocnice, Prague
Nemocnice na Bulovce, Prague
Policlinico Universitario Agostino Gemelli, Rome
Ospedale Civile, Sassari
USL Umbria 1 - Osp. Città di Castello, Città Di Castello (PG)
Hospital de Oncología Siglo XXI, Mexico City
Szpital Specjalistyczny Podkarpacki O?rodek Onkologiczny, Brzozów
Szpital Wojewódzki im. Miko?aja Kopernika, Koszalin
Ars Medical Sp. z o. o., Pi?a
MRUKMED Lekarz Beata Madej-Mruk i Partner Spolka Partnerska Oddzial nr 1 w Rzeszowie, Rzeszów
Hospital Garcia de Orta, Almada
IPO de Coimbra, Coimbra
IPO de Lisboa, Lisbon
Hospital de S. Francisco Xavier, Lisbon
Hospital Cuf Descobertas, Lisbon
IPO do Porto, Porto
Hospital General Universitario de Elche, Elche
Corporacio Sanitaria Parc Tauli, Sabadell
Hoffmann-La Roche
INDUSTRY